Article info
Clinical ethics
Commentary
Which newborns are too expensive to treat? A response to Dominic Wilkinson
- Correspondence to Professor Charles Camosy, Fordham University, 441 E. Fordham Rd., New York, NY 10458, USA; ccamosy{at}gmail.com
Citation
Which newborns are too expensive to treat? A response to Dominic Wilkinson
Publication history
- Received July 25, 2012
- Accepted August 3, 2012
- First published January 26, 2013.
Online issue publication
July 16, 2013
Article Versions
- Previous version (26 January 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Which newborn infants are too expensive to treat? Camosy and rationing in intensive care
- Authoritarian versus responsive communitarian bioethics
- Drawing the line in clinical treatment of companion animals: recommendations from an ethics working party
- Ethical dilemmas encountered by small animal veterinarians: characterisation, responses, consequences and beliefs regarding euthanasia
- Is providing elective ventilation in the best interests of potential donors?
- Infanticide and moral consistency
- Functional neuroimaging and withdrawal of life-sustaining treatment from vegetative patients
- Why active euthanasia and physician assisted suicide should be legalised
- Why I wrote my advance decision to refuse life-prolonging treatment: and why the law on sanctity of life remains problematic
- Withdrawal of clinically assisted nutrition and hydration decisions in patients with prolonged disorders of consciousness: best interests of the patients and advance directives are the keys